FDA inspection
Iovance Biotherapeutics Manufacturing, LLC: FDA inspection ending Aug 25, 2023
FDA inspection 1230147 · No Action Indicated (NAI) · Philadelphia, PA
Key facts
| Inspection ID | 1230147 |
|---|---|
| Firm | Iovance Biotherapeutics Manufacturing, LLC |
| FEI number | 3020882632 |
| Address | 300 Rouse Blvd |
| City | Philadelphia |
| State | PA |
| ZIP | 19112-1905 |
| Fiscal year | 2023 |
| Inspection end date | Aug 25, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data